Onos Health Banks $17M to Read Behavioral Health Notes
Fundraise Insider tracks newly funded startups each week and delivers verified sales leads of C-suite contacts straight to your inbox, so you reach the right people while the funding is still fresh. See pricing.
Onos Health has raised a $17 million Series A led by Costanoa, with strategic money from CVS Health Ventures and continued backing from Flare Capital Partners.
The company works out of San Francisco and builds clinical intelligence software aimed squarely at health plans and payers. It is one of a large cluster of digital health companies operating in California. The round follows a $6.3 million seed in October 2025 co-led by Haystack and Pathlight Ventures, bringing total funding to $23.5 million.
The problem Onos is chasing is a stubborn one. Mental health and substance use care has long been among the hardest categories for insurers to evaluate, affecting more than 23% of U.S. adults each year and accounting for over $140 billion in direct medical spend. Insurers mostly read billing codes, which say very little about whether a patient is actually getting better.
More than 70% of the meaningful clinical signals in this part of healthcare, things like treatment plans, symptom progression and therapy notes, sit inside unstructured clinician narratives that standard claims engines simply cannot read. What follows is an adversarial routine of manual chart pulls and blunt prior authorizations that irritates therapists and pushes back treatment for people who need it now.
Onos built a natural language processing engine to work through that material. Its software reads unstructured therapy notes, intake assessments and utilization histories, then judges whether the care delivered lines up with established clinical guidelines. The platform is not meant to stand in for clinicians. It automates back office chart review so payer medical directors can spot strong providers and catch care gaps earlier.
Results reported across health plan deployments give a sense of what that buys. Chart reviews run 75% faster, cutting turnaround times and reducing care delays. Adherence to evidence based standards improved 35%, benchmarked continuously across outpatient, intensive outpatient and residential programs. Total behavioral program costs fell by more than 6% within the first year, helped by fewer avoidable psychiatric readmissions and better steering toward high quality networks. The AI platform is currently running at Aetna and at three of the six largest health plans in the country.
The new capital will widen deployment of that engine across major commercial insurers, Medicare Advantage plans and Medicaid programs.
Companies selling services into newly funded health plans and care technology firms can reach verified decision makers through healthcare sales leads refreshed every week.